Article
Biochemistry & Molecular Biology
Wen-Yu Zhao, Xin-Yue Zhang, Mei-Rong Zhou, Xiang-Ge Tian, Xia Lv, Hou-Li Zhang, Sa Deng, Bao-Jing Zhang, Cheng-Peng Sun, Xiao-Chi Ma
Summary: The inhibition of soluble epoxide hydrolase (sEH) is considered an effective treatment for inflammation-related diseases. Two novel sEH inhibitors were identified from Alisma orientate, providing potential leads for the development of sEH inhibitors based on protostane-type triterpenoids. In-depth studies revealed the mechanism of inhibition and highlighted the role of amino acid residue Ser374 in the activity of the inhibitors.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
(2021)
Review
Cell Biology
Rebecca Charles, Philip Eaton
Summary: Cell responses to changes in redox state are mediated by reversible protein modifications, which can alter protein activities or interactions. These modifications are crucial for cells' homeostatic responses to environmental changes in redox state. The dysregulation of these redox regulatory mechanisms can contribute to pathophysiology. This review focuses on the redox control of soluble epoxide hydrolase (sEH), its different oxidative modifications, and their impact on cardiovascular physiology and disease progression during stress.
Article
Biochemistry & Molecular Biology
Wen-Yu Zhao, Juan-Juan Yan, Min Zhang, Chao Wang, Lei Feng, Xia Lv, Xiao-Kui Huo, Cheng-Peng Sun, Li-Xia Chen, Xiao-Chi Ma
Summary: The study found that the extract of Inula britanica exhibited inhibitory effects against sEH, leading to the isolation of several new compounds with significant inhibitory effects. Molecular docking and dynamics analysis suggested that compounds 10 and 13 could be potential candidates for the development of sEH inhibitors.
CHEMICO-BIOLOGICAL INTERACTIONS
(2021)
Article
Biochemistry & Molecular Biology
Nhien Nguyen, Christophe Morisseau, Dongyang Li, Jun Yang, Eileen Lam, D. Blake Woodside, Bruce D. Hammock, Pei-an Betty Shih
Summary: This study investigated the expression and activity of soluble epoxide hydrolase (sEH) in healthy women and women with anorexia nervosa. The results showed a correlation between sEH and body mass index, as well as a complex relationship with age and anxiety.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Yun Ding, Svetlana Belyanskaya, Jennifer L. DeLorey, Jeffrey A. Messer, G. Joseph Franklin, Paolo A. Centrella, Barry A. Morgan, Matthew A. Clark, Steven R. Skinner, Jason W. Dodson, Peng Li, Joseph P. Marino, David I. Israel
Summary: The inhibition of soluble epoxide hydrolase (sEH) has emerged as a new approach to treat cardiovascular and respiratory diseases. Through structure-activity relationship studies, inhibitors based on 1,3,5-triazine chemotype have been discovered, leading to the identification of a clinical candidate for COPD.
BIOORGANIC & MEDICINAL CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
Cindy B. McReynolds, Jun Yang, Alonso Guedes, Christophe Morisseau, Roberto Garcia, Heather Knych, Caitlin Tearney, Briana Hamamoto, Sung Hee Hwang, Karen Wagner, Bruce D. Hammock
Summary: This study examined the pharmacokinetics of a novel soluble epoxide hydrolase inhibitor, EC1728, in different animal species for the treatment of pain. Results showed varying drug exposures across species, emphasizing the importance of investigating therapeutic exposures in target species to ensure efficacy and avoid toxicity.
Article
Chemistry, Medicinal
Fangyu Du, Wenjiao Sun, Christophe Morisseau, Bruce D. Hammock, Xuefei Bao, Qiu Liu, Chao Wang, Tan Zhang, Hao Yang, Jun Zhou, Wei Xiao, Zhongbo Liu, Guoliang Chen
Summary: A new series of sEH inhibitors has been designed with improved binding properties and higher inhibition potency, among which compound B401 demonstrated potential therapeutic efficacy in sepsis. Molecular docking and in vitro studies supported the favorable activity of B401, highlighting its promise as a potential treatment for sepsis.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2021)
Article
Pharmacology & Pharmacy
Fangyu Du, Ruolin Cao, Lu Chen, Jianwen Sun, Yajie Shi, Yang Fu, Bruce D. Hammock, Zhonghui Zheng, Zhongbo Liu, Guoliang Chen
Summary: A new memantyl urea derivative, A20, was identified as a potent sEH inhibitor that can alleviate pain and improve the health status of rats, making it a promising candidate for the treatment of neuropathic pain.
ACTA PHARMACEUTICA SINICA B
(2022)
Article
Biochemistry & Molecular Biology
Jang Hoon Kim, Yun-Chan Huh, Mok Hur, Woo Tae Park, Youn-Ho Moon, Tae Il Kim, Yong Il Kim, Seon Mi Kim, Jeonghoon Lee, Ik Soo Lee
Summary: A Glycyrrhiza uralensis extract showed potential inhibition of sEH, a target enzyme for treating inflammation and cardiovascular disease. Compounds 1-11 were isolated and tested, with compound 10 exhibiting the strongest inhibitory activity. Further evaluation in cells and animals is needed for compound 10.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Biochemistry & Molecular Biology
Vladimir Burmistrov, Christophe Morisseau, Denis A. Babkov, Tatiana Golubeva, Dmitry Pitushkin, Elena Sokolova, Vladimir Vasipov, Yaroslav Kuznetsov, Sergey Bazhenov, Uliana S. Novoyatlova, Nikolay A. Bondarev, Ilya Manukhov, Victoria Osipova, Nadezhda Berberova, Alexander A. Spasov, Gennady M. Butov, Bruce D. Hammock
Summary: The newly synthesized inhibitor compounds showed effective inhibitory activity against inflammation and exhibited low cytotoxicity in cell assays.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Neurosciences
Christian Grinan-Ferre, Julia Jarne-Ferrer, Aina Bellver-Sanchis, Sandra Codony, Dolors Puigoriol-Illamola, Coral Sanfeliu, Yumin Oh, Seulki Lee, Santiago Vazquez, Merce Pallas
Summary: This study found that inhibiting soluble epoxide hydrolase (sEH) is helpful in combating neuroinflammation, and it can achieve neuroprotection by modulating the eIF2 alpha/CHOP pathway, which is of potential significance for the treatment of Alzheimer's disease.
CNS NEUROSCIENCE & THERAPEUTICS
(2023)
Article
Food Science & Technology
Jiamin Dang, Shuangkui Du, Liying Wang
Summary: This study demonstrated the inhibitory properties of corn gluten peptides on soluble epoxide hydrolase (sEH). Through virtual screening and experimental testing, peptides with high inhibitory activity were identified, which may serve as candidates for novel natural inhibitors.
Article
Biochemistry & Molecular Biology
Weimin Yu, Siqi Li, Haixia Wu, Pingping Hu, Lili Chen, Chunyu Zeng, Xiaoyong Tong
Summary: The study showed that inhibiting sEH can alleviate atherosclerosis caused by endothelial Nox4 dysfunction, potentially through suppression of ER stress. Endothelial Nox4 dysfunction can lead to inflammation, and inhibiting sEH and ER stress is beneficial for alleviating atherosclerosis.
FREE RADICAL BIOLOGY AND MEDICINE
(2021)
Article
Plant Sciences
Yoo Kyong Han, Ji Sun Lee, Seo Young Yang, Ki Yong Lee, Young Ho Kim
Summary: Compounds isolated from Lycopus lucidus, such as methyl rosmarinate, martynoside, dimethyl lithospermate, and 9 '' methyl lithospermate, showed significant inhibitory activity against sEH, making them potential candidates for further development in cardiovascular disease prevention and treatment.
Article
Chemistry, Medicinal
Irfan Capan, Paul M. Jordan, Abdurrahman Olgac, Burcu Caliskan, Christian Kretzer, Oliver Werz, Erden Banoglu
Summary: Two 1,3,4-oxadiazol-5-one and -thione congeners were identified as highly active sEH inhibitors, showing potential therapeutic effects on inflammation-related pathologies in cardiovascular, central nervous system, and metabolic diseases.
Article
Pharmacology & Pharmacy
Johanna H. M. Ehrler, Steffen Brunst, Amelie Tjaden, Whitney Kilu, Jan Heering, Victor Hernandez-Olmos, Andre Krommes, Jan S. Kramer, Dieter Steinhilber, Manfred Schubert-Zsilavecz, Susanne Muller, Daniel Merk, Ewgenij Proschak
Summary: This study presents the compilation and application of a focused screening library of fatty acid mimetics (FAMs), which are designed to bind proteins that accommodate natural fatty acids and lipid metabolites. Several hits were retrieved in screening the focused library against various fatty acid binding targets.
BIOCHEMICAL PHARMACOLOGY
(2022)
Article
Medicine, Research & Experimental
Luisa D. Burgers, Yanfen Li, Stylianos Michalakis, Sarah Ciurus, Stefan Zahler, Rolf Mueller, Robert Fuerst
Summary: This study provides evidence that vioprolide A (vioA) is an interesting compound with anti-angiogenic and anti-inflammatory effects. VioA reduced angiogenic features in endothelial cells by decreasing VEGFR2 protein levels and TAZ signaling. Surprisingly, vioA also promoted cell survival by activating Akt and inhibiting apoptosis. Further preclinical studies on vioA are warranted based on these findings.
BIOMEDICINE & PHARMACOTHERAPY
(2022)
Article
Biochemistry & Molecular Biology
Kai Breitwieser, Leon F. Koch, Tobias Tertel, Eva Proestler, Luisa D. Burgers, Christoph Lipps, James Adjaye, Robert Fuerst, Bernd Giebel, Meike J. Saul
Summary: Small extracellular vesicles (sEV) show great potential as biomarkers, drug carriers, and therapeutics. However, limited phenotypic characterization of sEV at the single vesicle level has resulted in sparse knowledge of cell type-specific sEV signatures. With the introduction of next-generation sEV analysis devices, such as the ExoView R100 platform, single sEV analyses are now possible, leading to a better understanding of the complexity and heterogeneity of sEV. The study demonstrates that tetraspanin composition in sEV varies among different cell types and can be influenced by cell culture conditions.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Pharmacology & Pharmacy
Marius Kreiss, Julia H. Oberlis, Sabine Seuter, Iris Bischoff-Kont, Duran Sueruen, Dominique Thomas, Tamara Goebel, Tobias Schmid, Olof Radmark, Ralf P. Brandes, Robert Fuerst, Ann-Kathrin Haefner, Dieter Steinhilber
Summary: This study reveals a noncanonical function of 5-LO as a transcriptional regulator in monocytic cells. Through gene knockout and RNA-Seq analysis, the study identifies 5-LO regulated genes and shows its effects on cell adhesion and tryptophan metabolism.
BIOCHEMICAL PHARMACOLOGY
(2022)
Article
Food Science & Technology
Pelin Erkoc, Bjoern Marcus von Reumont, Tim Lueddecke, Marina Henke, Thomas Ulshoefer, Andreas Vilcinskas, Robert Fuerst, Susanne Schiffmann
Summary: The venom of honeybees, specifically melittin peptides, has shown potential therapeutic effects on inflammation and cancer. This study explores the pharmacological activities of known and newly discovered melittin variants from honeybees and older solitary bees in the context of cancer and inflammation. The findings suggest that some ancestral variants from solitary bees have promising therapeutic potential in modulating inflammatory processes and inhibiting cancer cell viability/proliferation, including aggressive breast cancers.
Review
Chemistry, Multidisciplinary
Rita de Jesus, Kerstin Hiesinger, Manuel van Gemmeren
Summary: C-H activation is a promising method for increasing molecular complexity in drug synthesis. Despite facing challenges at a large scale, its advantages in shorter synthetic routes and simpler starting materials motivate chemists to explore its potential in pharmaceutical production. This review covers examples of drugs/drug candidates where C-H activation has been implemented on a preparative synthetic scale, analyzing the optimization processes and advantages and disadvantages for a comprehensive understanding of its challenges and potential in drug synthesis.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
(2023)
Article
Biochemistry & Molecular Biology
Marco J. J. Rotter, Sabrina Zentgraf, Lilia Weizel, Denia Frank, Luisa D. Burgers, Steffen Brunst, Robert Fuerst, Anna Proschak, Thomas A. Wichelhaus, Ewgenij Proschak
Summary: Metallo beta lactamases (MBLs) have become a major problem in treating multidrug-resistant Gram-negative pathogens due to their ability to resist a broad range of drugs and lack of effective inhibitors. In this study, we designed catechol-containing MBL inhibitors that mimic bacterial siderophores, which are actively taken up by bacteria through their iron acquisition system. The most potent catechol-containing MBL inhibitor demonstrated binding to Fe3+ ions and restored the effectiveness of imipenem in NDM-1-expressing K. pneumoniae without affecting healthy cells. These siderophore-containing MBL inhibitors could be a promising strategy to combat MBL-mediated resistance to beta lactam antibiotics.
Article
Cell Biology
Tobias F. Primke, Rebecca Ingelfinger, Mohammed A. F. Elewa, Igor Macinkovic, Andreas Weigert, Matthias P. Fabritius, Christoph A. Reichel, Angelika Ullrich, Uli Kazmaier, Luisa D. Burgers, Robert Fuerst
Summary: Research has found that depolymerizing microtubule-targeting agents can reduce inflammation by inhibiting the expression of pro-inflammatory molecules and decreasing leukocyte adhesion to endothelial cells. These agents not only affect leukocytes but also significantly decrease the inflammatory response of vascular endothelial cells. The study sets a baseline for further exploration of the anti-inflammatory effects of depolymerizing microtubule-targeting agents.
Article
Biochemistry & Molecular Biology
Lennart Schulte, Maik Damm, Ignazio Avella, Lilien Uhrig, Pelin Erkoc, Susanne Schiffmann, Robert Fuerst, Thomas Timm, Guenter Lochnit, Andreas Vilcinskas, Tim Lueddecke
Summary: Snakebite is an neglected tropical disease and the Vipers of the genus Macrovipera are medically important snakes in the Old World. This study presents the first proteomic evaluation of the venom from a Greek endemic Milos viper, revealing the presence of coagulotoxic and cytotoxic protein families. The research highlights the importance of further comparative studies across the genus Macrovipera for optimized treatment of envenomations.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2023)
Meeting Abstract
Pharmacology & Pharmacy
T. Zech, I. Bischoff-Kont, G. M. Krishnathas, L. Berger, S. Roesser, B. Stroedke, T. Schmid, S. Mueller, S. Knapp, F. Bracher, R. Fuerst
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
(2022)
Meeting Abstract
Pharmacology & Pharmacy
T. Primke, R. Ingelfinger, M. Fabritius, C. Reichel, A. Ullrich, U. Kazmaier, R. Fuerst
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
(2022)